Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children

Pediatric Infectious Disease Journal

Volumn 15, Issue 11, 1996, Pages 1025-1036

  Englund, Janet A ^a   Baker, Carol J ^a   Raskino, Claire ^b   Mckinney, Ross E ^c   Lifschitz, Marta H ^a   Petrie, Barbara ^d   Fowler, Mary Glenn ^e   Connor, James D ^f   Mendez, Hermann ^g   O'Donnell, Karen ^c   Wara, Diane W ^h   Behrman, Rachel ⁱ   Hetherington, Seth ^j   McLaren, Colin ^k   Millison, Karen ^l   Moye, Jack ^m   Nozyce, Molly ⁿ   Pearson, Deborah A ^o   Purdue, Lynette ^e   Schoenfeld, David ^b   Scott, Gwendolynn ^p   Spector, Stephen A ^f   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Frontier Science and Technology Research Foundation   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^j GLAXOSMITHKLINE   (United States)

^k BRISTOL MYERS SQUIBB   (United States)

^l ACTG Operations Office   (United States)

^m EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁿ BRONX LEBANON HOSPITAL CENTER   (United States)

^o UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Acquired immunodeficiency syndrome; antiretroviral therapy; children; cortical atrophy; development; didanosine; growth failure; human immunodeficiency virus; infection; zidovudine

Indexed keywords

ADOLESCENT; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHILD; CHILD DEVELOPMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GROWTH; HIV INFECTIONS; HUMANS; INFANT; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 0029828510     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199611000-00018     Document Type: Article

References (27)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. Centers for Disease Control. Update: AIDS among women: United States. MMWR 1995;44:82-5.
3. Butler KM, Husson RN, Balis FM, et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;324:137-44.
4. McKinney RE Jr, Maha MA, Connor EM, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 1991;324: 1018-25.
5. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987;36:225-36.
6. Dibley MJ, Goldsby JB, Staehling NW, et al. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-48.
7. Hamill PVV, Drizd TA, Johnson CL, et al. Physical growth: National Center for Health Statistics Percentiles. Am J Clin Nutr 1979;32:607-29.
8. Bayley, N. Bayley Scales of Infant Development: birth to two years. San Antonio, TX: Psychological Corp., 1969.
9. McCarthy DA. Manual for the McCarthy Scales of Children's Abilities. San Antonio, TX: Psychological Corp., 1972.
10. Wechsler D. Manual for the Wechsler Intelligence Scale for children: revised. San Antonio, TX: Psychological Corp., 1974.
11. Wechsler D. Manual for the Wechsler Adult Intelligence Scale: revised. San Antonio, TX: Psychological Corp., 1981.
12. Michalski FJ. The diagnosis of human immunodeficiency virus infection: progress in less than five years. Yale J Biol Med 1989;62:93-102.
13. Cox DR. The analysis of binary data. London: Methuen, 1970.
14. Draper N, Smith H. Applied regression analysis. 2nd ed. New York: Wiley, 1981.
15. McKinney RE, Wilfert CM. Lymphocyte subsets in children younger than 2 years old: normal values in a population at risk for human immunodeficiency virus infection and diagnostic and prognostic application to infected children. Pediatr Infect Dis J 1992;11:639-44.
16. Centers for Disease Control. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 1995:44(RR-4):1-11.
17. Davis SF, Byers RH, Lindegren ML, Caldwell B, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995;274:952-5.
18. Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome. Am J Dis Child 1988;142:29-35.
19. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk transmission. Lancet 1991;337:253-60.
20. Tovo PA, DeMartino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992;339:1249-53.
21. Blanche S, Tardieu M, Duliege A, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1990;144: 1210-6.
22. Brouwers P, DeCarli C, Civitello AL. Correlation between CT brain scan abnormalities and neuropsychological function in children with symptomatic HIV disease. Arch Neurol 1995; 52:39-44.
23. The European Collaborative Study. Neurologic signs in young children with human immunodeficiency virus infection. Pediatr Infect Dis J 1990;9:402-6.
24. Tardieu M, Mayaux J, Seibel N, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 1995;126:375-9.
25. The European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994;94:815-20.
26. Ogino MT, Danker WM, Spector SA. Development and significance of zidovudine resistance in children infected with human immunodeficiency virus. J Pediatr 1993;123:1-8.
27. Falloon J, Eddy J, Wiener L, et al. Human immunodeficiency virus infection in children. J Pediatr 1989;144:1-30.